0 2

SPECIAL GUEST & HOSTS

Exploring Mindfulness

As The New

Super Power

Featuring Special Guest

Dan Harris

Co-Anchor for both Nightline and the weekend edition of Good Morning America on ABC News, and a leading expert in mindfulness

Daniel MacIvor

Actor, playwright, theatre/film director, and recipient of the Governor General's Award

Event Co-Host:

Don McKellar

Actor, writer, filmmaker and member of the Order of Canada

Molly Johnson

Juno award winning singer-songwriter, artist, and philanthropist

Musical Entertainment:

0 5

CONTACT

For further information about the event or sponsorship opportunities, please contact:

PCCF: Courtney Jolliffe

cjolliffe@pccf.ca or 416-548-8077 ext. 4

CFHU: Merle Goldman

mgoldman@cfhu.org or 416-485-8000

0 3

SPONSORSHIP

Invest in a future without pancreatic cancer. Consider sponsoring the ground-breaking collaborative research supported by this forward-thinking and timely collaboration between Canadian Friends of Hebrew University (CFHU) and Pancreatic Cancer Canada (PCCF) at the Collaborating for a Cure evening on October 19th. A tax receipt for the maximum allowable amount will be issued.

SPONSORSHIP LEVELS

Associate Professor

$10,000

8 tickets
Reserved VIP Seating
Exclusive pre-event dinner and meet and greet with Dan Harris, Co-anchor for both Nightline and the weekend edition of Good Morning America on ABC News, as well as key pancreatic cancer researchers
VIP recognition on marketing materials (invitation, e-blasts, event evening program)
Associate Professor sponsor recognition on signage and video loop at event
Recognition on PCCF and CFHU websites and in event social media

Fellow

$2,500

4 tickets
Reserved sponsor seating
Fellow sponsor recognition on signage, video loop and evening program at event
Recognition on PCCF and CFHU websites and in event social media

PhD

$1000

2 tickets
Reserved sponsor seating
PhD sponsor recognition on signage, video loop and evening program at event

Dean

$50,000

20 tickets
Reserved VIP Seating
Exclusive pre-event dinner and meet and greet with Dan Harris, Co-anchor for both Nightline and the weekend edition of Good Morning America on ABC News, as well as key pancreatic cancer researchers
Premier recognition as Dean sponsor on all marketing materials (invitation, e-blasts, event evening program)
Dean Sponsor recognition on signage and video loop at event
Premier recognition on PCCF and CFHU websites and in event social media

Professor Emeritus

$25,000

14 tickets
Reserved VIP Seating
Exclusive pre-event dinner and meet and greet with Dan Harris, Co-anchor for both Nightline and the weekend edition of Good Morning America on ABC News, as well as key pancreatic cancer researchers
Exclusive recognition as Professor Emeritus sponsor on all marketing materials (invitation, e-blasts, event evening program)
Professor Emeritus sponsor recognition on signage and video loop at event
Recognition on PCCF and CFHU websites and in event social media

Professor

$18,000

10 tickets
Reserved VIP Seating
Exclusive pre-event dinner and meet and greet with Dan Harris, Co-anchor for both Nightline and the weekend edition of Good Morning America on ABC News, as well as key pancreatic cancer researchers
Prominent recognition on marketing materials (invitation, e-blasts, event evening program)
Professor sponsor recognition on signage and video loop at event
Recognition on PCCF and CFHU websites and in event social media

Pancreatic Plaque Inscription

$36

For an additional $36 donation, you can honour a friend or family member touched by Pancreatic Cancer
Their name will be inscribed on a plaque that will be placed in a Pancreatic Cancer research lab in Toronto and Israel
These names will also be on a video loop at the event

Note: Inclusion on event promotions and print materials will be determined by distribution and print deadlines

Individual Ticket

$150

General admission seating

Lecturer

$5,000

6 tickets
Reserved VIP Seating
Lecturer sponsor recognition on signage, video loop and evening program at event
Recognition on PCCF and CFHU websites and in event social media

Pancreatic cancer will be the #2 cancer killer by 2020; that is just a little over two years from now! This is due to how little is still known about this disease (and how to treat it) as well as its increased incidence. The current 5-year survival rate is roughly 7% - in other terms, 93% of people diagnosed with pancreatic cancer die within 5 years and most within just a few months. This is not an old person’s disease; it targets people at all ages and impacts young and dependent families as well as those in their retirement years.

0 1

ABOUT

Innovation and collaboration is the key to solving the deadly puzzle of pancreatic cancer. It is therefore with a strong sense of urgency that a leading group of cancer researchers and clinicians in Canada and Israel have joined forces to better understand this devastating illness, first at the genomic level and then to translate those findings in clinical testing to offer patients real hope for a longer life.

Your donations will directly support the continuation of cutting-edge research which is already yielding promising results:

The Alex U. Soyka Pancreatic Cancer Project, a Canadian- Israeli collaboration focused on uncovering the genetic drivers of pancreatic metastatic cancer

COMPASS, a world-leading molecular profiling study of tumors from patients with advanced cancer

Our prestigious team of international pancreatic cancer experts includes Dr. Steven Gallinger at Princess Margaret Cancer Centre/UHN/Mount Sinai Hospital, Dr. Ittai Ben-Porath in concert with four other investigators at The Hebrew University of Jerusalem, Dr. Lincoln Stein and his team at the Ontario Institute for Cancer Research, and Dr. Talia Golan of Sheba Medical Center in Tel Aviv.

Pancreatic Cancer Canada (PCCF) is a national charity with the dual focus of funding research and providing support to people living with pancreatic cancer. 100% of the PCCF research budget is focused on PCCF’s PancOne™ which encompasses 5 Centres of Excellence (and 2 Supporting Centres) across Canada in pancreatic cancer research. PancOne™ provides a structure wherein researchers collaborate on individual projects and trials with the work and funds divided based on the specialty of each Centre. The project currently being funded is focused on developing pan-Canadian integrative profiling initiatives to lead to individualized and precision- based treatments for all patients with pancreatic cancer.

Funding for this event will also go towards the expansion of PancOne™ to Israel.

Thanks to the vision of the Soyka Pancreatic Cancer Research Project, The Hebrew University of Jerusalem’s Institute for Medical Research Israel-Canada has a team of five researchers who have been collaborating with scientists at the Ontario Institute for Cancer Research and Toronto’s Princess Margaret Centre.

The multi-pronged goals of these research and trial programs are:

detailed molecular analysis of patient tumors, in real time, to reveal their particular genetic composition and develop protocols for optimal matched treatment;
development of disease models that allow the detailed investigation of how pancreatic cancer develops;
testing of new diagnosis and treatment methods;
and development of a strategy for early detection of the cancer, which would lead to reduced mortality.

0 4

SPONSORS

Our sponsors help support the future of pancreatic cancer research. We are thankful for their vision and commitment to The Hebrew University of Jerusalem.

Lead Sponsorship

Sylvia Soyka Family

Media Sponsor